Metraipolis › archive › dc_8a331d60a13f

New Frontier in Cancer Immunotherapy: Sexual Dimorphism of Immune Response — Europe PMC PMID:41295272

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41295272
DOI: 10.3390/metabo15110686
License (as archived): solo-consultazione
Archived: 2026-11-09T02:58:07.969Z
SHA-256 of the archived text: 3de0ab19d46ef16d3aca653e73e89a117a867ea74b0722ec51186d466674b05a
Stable URL of this page: https://metraipolis.com/documento/dc_8a331d60a13f

How to cite

New Frontier in Cancer Immunotherapy: Sexual Dimorphism of Immune Response — Europe PMC PMID:41295272 — Europe PMC (en), https://europepmc.org/article/MED/41295272 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_8a331d60a13f (Metraipolis archive dc_8a331d60a13f, sha256 3de0ab19d46ef16d3aca653e73e89a117a867ea74b0722ec51186d466674b05a)

BibTeX

@misc{dc8a331d60a13f,
  title = {New Frontier in Cancer Immunotherapy: Sexual Dimorphism of Immune Response — Europe PMC PMID:41295272},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41295272},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_8a331d60a13f; sha256 3de0ab19d46ef16d3aca653e73e89a117a867ea74b0722ec51186d466674b05a},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41295272. Agents can read the archived copy with the MCP tool read_document.